Extended spectrum beta-lactamases: a therapeutic dilemma
- 1 October 2002
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 21 (10) , 957-959
- https://doi.org/10.1097/00006454-200210000-00014
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Association of Antibiotic Utilization Measures and Control of Multiple-Drug Resistance inKlebsiella pneumoniaeInfection Control & Hospital Epidemiology, 2000
- Epidemiology of Ciprofloxacin Resistance and Its Relationship to Extended-Spectrum -Lactamase Production in Klebsiella pneumoniae Isolates Causing BacteremiaClinical Infectious Diseases, 2000
- Survey of Bloodstream Infections Due to Gram-Negative Bacilli: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997Clinical Infectious Diseases, 1999
- ANTIMICROBIAL RESISTANCE IN INTENSIVE CARE UNITSClinics in Chest Medicine, 1999
- Class Restriction of Cephalosporin Use to Control Total Cephalosporin Resistance in Nosocomial KlebsiellaJAMA, 1998
- Evidence of Interhospital Transmission of Extended-Spectrum β-Lactam-Resistant Klebsiella pneumoniae in the United States, 1986 to 1993Infection Control & Hospital Epidemiology, 1997
- Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical CenterClinical Infectious Diseases, 1996
- Guideline for isolation precautions in hospitals Part I. Evolution of isolation practicesAmerican Journal of Infection Control, 1996
- Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation CephalosporinsAnnals of Internal Medicine, 1993
- Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patientsAntimicrobial Agents and Chemotherapy, 1992